Healthcare Stocks
-
Yahoo Finance Analysis: Amgen is a More Robust Healthcare Stock Investment Choice Than CRISPR Therapeutics in 2026
Yahoo Finance analysis suggests that in 2026, traditional pharmaceutical giant Amgen is a more stable investment choice compared to gene-editing pioneer CRISPR Therapeutics. The report indicates that
-
Yahoo Finance analysis favors Eli Lilly over AbbVie for 2026 healthcare stock investment
Yahoo Finance analysis suggests Eli Lilly and Co (LLY) is a better healthcare stock buy for 2026 compared to AbbVie Inc (ABBV), citing Eli Lilly's strong growth in metabolic and obesity platforms driv
-
AbbVie is considered a better healthcare stock pick than Johnson & Johnson for 2026, with its net income projected to surge to $14.6 billion.
An analysis from Yahoo Finance highlights AbbVie's impressive R&D pipeline and higher upside potential, projecting its net income to surge from $4.2 billion to $14.6 billion this fiscal year, with sal
-
Wall Street Investors Turn to Healthcare Stocks, S&P 500 Healthcare Index Reaches All-Time High
Investors are pouring money into U.S. healthcare stocks, betting the sector will extend a rally after years of underperformance, driven by improving earnings, increased deal activity, and attractive v
-
Yahoo Finance Analysis: Amgen is a More Robust Healthcare Stock Investment Choice Than CRISPR Therapeutics in 2026
Yahoo Finance analysis suggests that in 2026, traditional pharmaceutical giant Amgen is a more stable investment choice compared to gene-editing pioneer CRISPR Therapeutics. The report indicates that
-
Yahoo Finance analysis favors Eli Lilly over AbbVie for 2026 healthcare stock investment
Yahoo Finance analysis suggests Eli Lilly and Co (LLY) is a better healthcare stock buy for 2026 compared to AbbVie Inc (ABBV), citing Eli Lilly's strong growth in metabolic and obesity platforms driv
-
AbbVie is considered a better healthcare stock pick than Johnson & Johnson for 2026, with its net income projected to surge to $14.6 billion.
An analysis from Yahoo Finance highlights AbbVie's impressive R&D pipeline and higher upside potential, projecting its net income to surge from $4.2 billion to $14.6 billion this fiscal year, with sal
-
Wall Street Investors Turn to Healthcare Stocks, S&P 500 Healthcare Index Reaches All-Time High
Investors are pouring money into U.S. healthcare stocks, betting the sector will extend a rally after years of underperformance, driven by improving earnings, increased deal activity, and attractive v
- No data
Healthcare Stocks
24H Trending
-
1
Turkish investment bank Tera Group collapsed, with $14 billion in funds liquidated. The Department of Justice characterized it as a "Ponzi-like scheme."
-
2
"Crypto King" Barry Silbert is shifting DCG institutional capital towards AI token Bittensor (TAO), calling it the most exciting project since Bitcoin.
-
3
After the UK sanctioned HTX, TRON Inc. began receiving TRX through an intermediary wallet funded by HTX.
-
4
Nigerian Firms Seek Regulatory Approval to Attract African Investors for Dangote Refinery IPO
-
5
Allen Media Group CEO Byron Allen Emphasizes Deleveraging After Company Loans Hit Low
-
6
Radix blockchain suffers $1.3 million drain due to 3-year-old bug, forcing 10-day halt
-
7
Musk Predicts: AI to Double US GDP Growth from ~2% to ~4% or Even Higher Next Year
-
8
AI data center company Nscale has publicly filed for a U.S. IPO, seeking to raise up to $3 billion. NVIDIA holds over 5% of its shares, and it has secured a $45 billion lease commitment from Anthropic.
-
9
90 million USDC (approximately $90 million) minted on-chain.
-
10
Partners Group is exploring an €800 million ($917 million) fund to hold its private credit loans longer
Markets Today
Recommended Reading
